Drug availability is an issue for cancer patients, too

Humphrey visual field findings in hydroxychloroquine toxicity.

Eye (London, England)·2011

Comparison of MRSASelect Agar, CHROMagar Methicillin-Resistant Staphylococcus aureus (MRSA) Medium, and Xpert MRSA PCR for detection of MRSA in Nares: diagnostic accuracy for surveillance samples with various bacterial densities.

Journal of clinical microbiology·2009

Retinopathy of prematurity: evaluation of risk factors.

International ophthalmology·2000

Degeneration of cone photoreceptors induced by expression of the Mas1 protooncogene.

Experimental neurology·2000

Ocular injuries from paintball pellets.

Ophthalmology·1999

Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Visual prognosis of patients treated with ganciclovir and/or foscarnet.

Ophthalmology·1996

Touch and pain shape what brain imaging sees.

Science (New York, N.Y.)·2026

Beyond carbon in renewable energy policy.

Science (New York, N.Y.)·2026

Tracing the origins of de novo coronary collateral formation in cardiac repair.

Science (New York, N.Y.)·2026

Redirecting wet-interfacial redox pathways for efficient inverted perovskite solar cells.

Science (New York, N.Y.)·2026

Key animal and plant disease lab stalled by biosafety issues.

Science (New York, N.Y.)·2026

Powers of persuasion.

Science (New York, N.Y.)·2026

Environmental endocrine disruptors activate CBX2 to disrupt cholesterol homeostasis in PCOS.

The Journal of steroid biochemistry and molecular biology·2026

Phytochemical characterization of methanolic extract of Cuminum cyminum seeds and its anticancer efficacy against human oral cancer.

Tissue & cell·2026

Schisandrin B protects against oxaliplatin-induced liver injury by suppressing ferroptosis via the canonical KEAP1-Nrf2 and non-canonical microbiota-driven Lactobacillus reuteri-CLA-Nrf2 axes.

Pharmacological research·2026

Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathway.

Translational oncology·2026

A synergistic cascade nanoreactor breaks bladder cancer chemoresistance: Synergizing cholesterol metabolism reprogramming with cGAS-STING-mediated metallotherapy.

Materials today. Bio·2026

Motivations, Decision-Making, and Barriers to Treatment Innovation Adoption: A Mixed-Methods Study of Addiction Treatment Executives.

Research square·2026

Related Experiment Videos

Drug availability is an issue for cancer patients, too

Related Concept Videos

Humphrey visual field findings in hydroxychloroquine toxicity.

Comparison of MRSASelect Agar, CHROMagar Methicillin-Resistant Staphylococcus aureus (MRSA) Medium, and Xpert MRSA PCR for detection of MRSA in Nares: diagnostic accuracy for surveillance samples with various bacterial densities.

Retinopathy of prematurity: evaluation of risk factors.

Degeneration of cone photoreceptors induced by expression of the Mas1 protooncogene.

Ocular injuries from paintball pellets.

Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Visual prognosis of patients treated with ganciclovir and/or foscarnet.

Touch and pain shape what brain imaging sees.

Beyond carbon in renewable energy policy.

Tracing the origins of de novo coronary collateral formation in cardiac repair.

Redirecting wet-interfacial redox pathways for efficient inverted perovskite solar cells.

Key animal and plant disease lab stalled by biosafety issues.

Powers of persuasion.

Environmental endocrine disruptors activate CBX2 to disrupt cholesterol homeostasis in PCOS.

Phytochemical characterization of methanolic extract of Cuminum cyminum seeds and its anticancer efficacy against human oral cancer.

Schisandrin B protects against oxaliplatin-induced liver injury by suppressing ferroptosis via the canonical KEAP1-Nrf2 and non-canonical microbiota-driven Lactobacillus reuteri-CLA-Nrf2 axes.

Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathway.

A synergistic cascade nanoreactor breaks bladder cancer chemoresistance: Synergizing cholesterol metabolism reprogramming with cGAS-STING-mediated metallotherapy.

Motivations, Decision-Making, and Barriers to Treatment Innovation Adoption: A Mixed-Methods Study of Addiction Treatment Executives.

Related Experiment Videos

Drug availability is an issue for cancer patients, too

Related Concept Videos

Related Articles